Related Experiment Videos
Adenosine receptors and their ligands
1Institut für Pharmakologie und Toxikologie, Universität Würzburg, Germany. klotz@toxi.uni-wuerzburg.de
Naunyn-Schmiedeberg'S Archives of Pharmacology
|December 9, 2000
Summary
Adenosine receptors (A1, A2A, A2B, A3) are key drug targets. However, developing highly selective ligands for human adenosine receptor subtypes remains challenging despite extensive research.
Area of Science:
- Pharmacology
- Biochemistry
- Medicinal Chemistry
Background:
- Adenosine receptors (A1, A2A, A2B, A3) are G protein-coupled receptors found on most cells.
- These receptors play crucial roles in various pathophysiological conditions, making them attractive pharmacological targets.
Purpose of the Study:
- To review the current landscape of adenosine receptor ligands.
- To highlight challenges in developing subtype-selective compounds for human adenosine receptors.
Main Methods:
- Review of existing literature on adenosine receptor pharmacology.
- Comparative analysis of ligand selectivity across different species, focusing on human receptor subtypes.
Main Results:
- A vast array of agonists and antagonists for adenosine receptors have been synthesized.
- Many compounds previously considered selective show unexpected potencies at human receptor subtypes.
- Achieving high affinity for a single adenosine receptor subtype is rare.
Conclusions:
- Despite a large number of available ligands, satisfying selectivity for most adenosine receptor subtypes is lacking.
- Further research is needed to develop truly selective ligands for therapeutic intervention.